Peter Sasieni

26.8k total citations · 5 hit papers
308 papers, 15.4k citations indexed

About

Peter Sasieni is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Peter Sasieni has authored 308 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Oncology, 133 papers in Epidemiology and 59 papers in Surgery. Recurrent topics in Peter Sasieni's work include Cervical Cancer and HPV Research (113 papers), Global Cancer Incidence and Screening (107 papers) and Colorectal Cancer Screening and Detection (54 papers). Peter Sasieni is often cited by papers focused on Cervical Cancer and HPV Research (113 papers), Global Cancer Incidence and Screening (107 papers) and Colorectal Cancer Screening and Detection (54 papers). Peter Sasieni collaborates with scholars based in United Kingdom, United States and France. Peter Sasieni's co-authors include Jack Cuzick, Alejandra Castañón, Francesca Pesola, Rebecca Landy, Jo Adams, Chris J.L.M. Meijer, Christine Clavel, David Mesher, Amar Ahmad and Anne Szarewski and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Peter Sasieni

304 papers receiving 14.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy

2019 898 citations Peter Hájek, Anna Phillips‐Waller et al. profile →
Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2006 856 citations Jack Cuzick, Peter Sasieni et al. International Journal of Cancer profile →
From Genotypes to Genes: Doubling the Sample Size

1997 701 citations Peter Sasieni profile →
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy

2008 541 citations Peter Sasieni et al. profile →
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

2021 414 citations Milena Falcaro, Alejandra Castañón et al. profile →

Peers

Countries citing papers authored by Peter Sasieni

Since Specialization

Citations

This map shows the geographic impact of Peter Sasieni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sasieni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sasieni more than expected).

Fields of papers citing papers by Peter Sasieni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sasieni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sasieni. The network helps show where Peter Sasieni may publish in the future.

Co-authorship network of co-authors of Peter Sasieni

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sasieni. A scholar is included among the top collaborators of Peter Sasieni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sasieni. Peter Sasieni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Matejka Rebolj, Adam R. Brentnall, Julia Geppert, (unknown), Bethany Shinkins, Karoline Freeman, Chris Stinton, (unknown), Samantha Johnson, Robert A. Smith, Peter Sasieni, Sam M. Janes, Ruth Etzioni, Stephen W. Duffy, Sian Taylor‐Phillips	1
2	Interventions for patients with prostate cancer on active surveillance: a narrative review 2025 ·British Journal of Urology ·(unknown), Runzhi Chen, Benjamin W. Lamb, Caroline M. Moore, James W.F. Catto, Jack Cuzick, Peter Sasieni, Prabhakar Rajan	0
3	Optimising brain age estimation through transfer learning: A suite of pre‐trained foundation models for improved performance and generalisability in a clinical setting 2024 ·Human Brain Mapping ·David Wood, Matthew Townend, (unknown), (unknown), (unknown), (unknown), (unknown), Asif Mazumder, Peter Sasieni, Gareth J. Barker, Sébastien Ourselin, James H. Cole, Thomas C. Booth	11
4	Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study 2024 ·BMJ ·Milena Falcaro, Kate Soldan, B Ndlela, Peter Sasieni	27
5	Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine? 2024 ·Journal of Clinical Oncology ·Peter Sasieni	3
6	Managing an extension of screening intervals: Avoiding boom and bust in health care workloads 2023 ·International Journal of Cancer ·Francesca Pesola, Matejka Rebolj, Peter Sasieni	2
7	Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk 2023 ·BMJ Open ·James W.F. Catto, Bernard V. North, (unknown), (unknown), Michelle Sleeth, Olena Mandrik, J. Chilcott, Peter Sasieni, Marcus Cumberbatch	3
8	Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy 2023 ·Health Technology Assessment ·Dunja Przulj, Francesca Pesola, Katie Myers Smith, Hayden McRobbie, Tim Coleman, Sarah Lewis, (unknown), Robert Walton, Rachel Whitemore, Elizabeth Clark, Michael Ussher, Lesley Sinclair, (unknown), Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda, Peter Hájek	4
9	Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial 2022 ·Nature Medicine ·Peter Hájek, Dunja Przulj, Francesca Pesola, Chris Griffiths, Robert Walton, Hayden McRobbie, Tim Coleman, Sarah Lewis, Rachel Whitemore, Elizabeth Clark, Michael Ussher, Lesley Sinclair, (unknown), Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda, Katie Myers Smith	37
10	Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study 2022 ·JNCI Journal of the National Cancer Institute ·Alejandra Castañón, Dharmishta Parmar, Nathalie J. Massat, Peter Sasieni, Stephen W. Duffy	3
11	Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Alejandra Castañón, Aruna Kamineni, K. Miriam Elfström, Anita WW Lim, Peter Sasieni	3
12	A case-control study to evaluate the impact of the breast screening programme on mortality in England 2020 ·British Journal of Cancer ·Roberta Maroni, Nathalie J. Massat, Dharmishta Parmar, Amanda Dibden, Jack Cuzick, Peter Sasieni, Stephen W. Duffy	31
13	Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales 2020 ·BJOG An International Journal of Obstetrics & Gynaecology ·Francesca Pesola, Matejka Rebolj, Simon Leeson, (unknown), L Pickford, Ardiana Gjini, Peter Sasieni	6
14	Cost‐effectiveness of e‐cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial 2019 ·Addiction ·Jinshuo Li, Peter Hájek, Francesca Pesola, Qi Wu, Anna Phillips‐Waller, Dunja Przulj, Katie Myers Smith, Natalie Bisal, Peter Sasieni, Lynne Dawkins, Louise Ross, Maciej Ł. Goniewicz, Hayden McRobbie, Steve Parrott	27
15	E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT 2019 ·Health Technology Assessment ·Peter Hájek, Anna Phillips‐Waller, Dunja Przulj, Francesca Pesola, Katie Myers Smith, Natalie Bisal, Jinshuo Li, Steve Parrott, Peter Sasieni, Lynne Dawkins, Louise Ross, Maciej Ł. Goniewicz, Qi Wu, Hayden McRobbie	49
16	Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline 2017 ·Obstetrical & Gynecological Survey ·José Jerónimo, Philip E. Castle, Sarah Temin, Lynette Denny, Vandana Gupta, Jane J. Kim, Silvana Luciani, Daniel Murokora, Twalib Ngoma, You‐Lin Qiao, Michael Quinn, Rengaswamy Sankaranarayanan, Peter Sasieni, Kathleen M. Schmeler, Surendra S. Shastri	2
17	Cancer mortality in the United Kingdom: projections to the year 2025 2008 ·British Journal of Cancer ·Anne Helene Olsen, Donald Maxwell Parkin, Peter Sasieni	66
18	An adaptive variable span running line smoother 1998 ·Stata technical bulletin ·Peter Sasieni	6
19	Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study 1996 ·British Journal of Cancer ·Véronique Bataille, (unknown), Peter Sasieni, Anthony J. Swerdlow, Elizabeth Pinney, (unknown), Jack Cuzick	160
20	Non-orthogonal projections and their application to calculating the information in a partly linear Cox model 1992 ·Scandinavian Journal of Statistics ·Peter Sasieni	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact